Baluran, Merlyn N.
HRN: 24-42-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2024
CEFTAZIDIME 1GM (VIAL)
07/23/2024
07/30/2024
IV
1g
Q8H
HAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes